Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide
Open Access
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (5), 729-736
- https://doi.org/10.1016/j.bbmt.2010.08.018
Abstract
No abstract availableKeywords
Funding Information
- Genzyme
This publication has 18 references indexed in Scilit:
- Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimensBlood, 2009
- Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaBlood, 2009
- Advances in mobilization for the optimization of autologous stem cell transplantationLeukemia & Lymphoma, 2009
- Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesisBlood, 2008
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer, 2006
- Costs and Cost Effectiveness of a Health Care Provider–Directed Intervention to Promote Colorectal Cancer Screening Among VeteransJournal of Clinical Oncology, 2005
- Kinetics of Peripheral Blood Stem Cell Mobilization Following G‐CSF‐Supported ChemotherapyThe International Journal of Cell Cloning, 2003
- A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSFBone Marrow Transplantation, 2000
- Is There Any Difference in PBPC Mobilization Between Cyclophosphamide Plus G-CSF and G-CSF Alone in Patients with Non-Hodgkin's Lymphoma?Leukemia & Lymphoma, 2000
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995